Sagimet Biosciences Inc Series A Common Stock (SGMT) had the highest return between January 19, 2024 and January 22, 2024 by a small-cap US stock, returning 180.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Sagimet Biosciences Inc Series A Common Stock (SGMT) | 1/19/2024 - 1/22/2024 | 180.79% |
Clene (CLNNW) | 1/19/2024 - 1/22/2024 | 43.71% |
Dianthus Therapeutics (DNTH) | 1/19/2024 - 1/22/2024 | 39.57% |
Esperion Therapeutics (ESPR) | 1/19/2024 - 1/22/2024 | 28.74% |
Edgewise Therapeutics (EWTX) | 1/19/2024 - 1/22/2024 | 26.32% |
NRx Pharmaceuticals (NRXPW) | 1/19/2024 - 1/22/2024 | 24.57% |
Spyre Therapeutics (SYRE) | 1/19/2024 - 1/22/2024 | 24.56% |
Astria Therapeutics (ATXS) | 1/19/2024 - 1/22/2024 | 24.54% |
SS Innovations International Inc Common Stock (SSII) | 1/19/2024 - 1/22/2024 | 22.64% |
Innoviz Technologies (INVZW) | 1/19/2024 - 1/22/2024 | 21.79% |
Vertical Aerospace (EVTL) | 1/19/2024 - 1/22/2024 | 21.04% |
Innodata (INOD) | 1/19/2024 - 1/22/2024 | 20.87% |
POET Technologies (POET) | 1/19/2024 - 1/22/2024 | 18.95% |
Upexi (UPXI) | 1/19/2024 - 1/22/2024 | 18.87% |
Eos Energy Enterprises (EOSE) | 1/19/2024 - 1/22/2024 | 18.7% |
Immunome (IMNM) | 1/19/2024 - 1/22/2024 | 18.02% |
Lendingtree (TREE) | 1/19/2024 - 1/22/2024 | 17.46% |
Cullinan Oncology LLC (CGEM) | 1/19/2024 - 1/22/2024 | 17.19% |
Beauty Health (SKIN) | 1/19/2024 - 1/22/2024 | 16.6% |
Real Brokerage (REAX) | 1/19/2024 - 1/22/2024 | 16.14% |
Rackspace Technology (RXT) | 1/19/2024 - 1/22/2024 | 15.85% |
Standard Lithium (SLI) | 1/19/2024 - 1/22/2024 | 15.83% |
A2Z Smart Technologies (AZ) | 1/19/2024 - 1/22/2024 | 14.68% |
MBIA (MBI) | 1/19/2024 - 1/22/2024 | 14.64% |
Oatly Group AB ADR (OTLY) | 1/19/2024 - 1/22/2024 | 14.56% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
